Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02700074
Other study ID # 3077E
Secondary ID P50DC013027
Status Completed
Phase
First received
Last updated
Start date February 2015
Est. completion date August 30, 2019

Study information

Verified date January 2020
Source Boston University Charles River Campus
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main goal of our study is to find out why some people with Autism Spectrum Disorder (ASD) do not develop verbal abilities or remain minimally-verbal throughout adolescence and adulthood. Current research focuses on investigating brain differences related to processing sounds and initiating speech in adolescents and young adults with ASD varying in language skills, compared to adolescents who do not have ASD, in order to clarify whether atypical processes of auditory perception, perceptual organization and/or neural oscillation patterns may explain why some individuals with ASD fail to acquire functional speech.


Description:

About 30% of children with Autism Spectrum Disorder (ASD) fail to acquire spoken language. This group of children has been seriously neglected in research conducted over the past 2 decades. Little is known about them, in part because the field lacks the tools to assess them, and they often pose significant behavioral challenges that preclude their participation in research studies. Among the ~70% individuals with ASD who have spoken language skills, about 50% are language impaired; the remaining group have normal language scores on standardized tests. Thus, there is enormous heterogeneity in verbal abilities in ASD. To date, studies of the brain and cognitive mechanisms that underlie this heterogeneity remain quite limited.

At the cognitive level, current research suggests that language impairment in verbal children with ASD involves deficits in phonological working memory, as evident on tests of nonsense word repetition. The areas of language that are most affected in this group include complex syntax and morphology related to marking tense (Tager-Flusberg et al., 2005). There is also considerable evidence from MRI (magnetic resonance imaging) studies of both children and adults that there are differences in volume and asymmetry in language regions of the cortex, specifically Broca's and Wernicke's areas. Recent studies suggest that these differences do not necessarily track with degree of language impairment, though there are conflicting findings in the literature. Importantly, most of the participants in cognitive and neuroimaging studies of ASD have been adults and individuals who have relatively intact language. Far less is known about the processes (either cognitive or neural) that might be implicated in the minimally verbal group. This project is designed to address this issue using two different brain imaging methods and approaches.

1. fMRI and DTI: Converging lines of evidence support the view that ASDs are disorders of connectivity, in which abnormalities in white matter integrity and reduced coordination of activity across brain regions give rise to core features. Recent results from our group (Guenther; Manoach) have identified white matter anomalies in the speech network of high-functioning verbal adults with ASD, specifically in the pathway between the left supplementary motor area (SMA) and left ventral premotor cortex (vPMC), a pathway involved in the initiation of speech output according to the Directions into Velocities of Articulators (DIVA) model of speech production, a leading model of the neural computations underlying speech. These connectivity abnormalities are revealed in both DTI and functional connectivity analyses collected using fMRI. NOTE: IRB approval for the collection of fMRI/DTI data will be obtained from MGH, where this portion of the study will be carried out. Data analyses will be carried out at MGH and BU.

2. Electrophysiology: EEG/ERP It has long been known that some children with ASD fail to respond when spoken to, cover their ears in the presence of certain sounds, yet show highly acute hearing in other contexts. Little is known about the mechanisms that might underlie these unusual auditory processing profiles. Abnormal neural oscillations have been found to be an endophenotype for ASD in infants and adults. However, the picture of how oscillations differ from those of non-clinical subjects is unclear and depends on the age at testing. Characterizing the oscillations present in the brains of a range of adolescents will allow us to quantify the relationship between neural activity and severity of language impairment. The main hypothesis that will be tested in this project is that abnormal neural connectivity in minimally verbal children with ASD profoundly impedes the ability to perceptually organize auditory scenes into meaningful units or objects, which has a direct effect on language development in these individuals. Event-related brain potentials (ERPs) and frequency-based analysis of the electroencephalogram (EEG) will be collected during passive listening tasks, to evaluate auditory perception and the perceptual organization of tones and speech using the mismatch negativity (MMN) paradigm (the MMN reflects passive deviance detection processes indexing low-level acoustic processes in automatic sensory memory mechanisms, and it has been widely investigated in studies of auditory perceptual discrimination of tones and speech).

The investigators plan to collect these data from 3 groups of adolescents with ASD varying in language skills (minimally verbal, verbal-language impaired, verbal-language normal) and age and gender matched non-ASD typical adolescents. The participants will be diagnosed and tested using a range of standardized and non-standardized assessments including IQ/cognitive level; social abilities; ASD severity; communication skills (nonverbal). These assessments will be carried out by trained examiners in the clinical core housed at BU.

Because many of the participants present with highly challenging behaviors and are difficult to test, a number of innovative approaches will be taken to maximize participants' success in completing the behavioral assessments, and then to tolerate and provide artifact-free data in the electrophysiological and MRI portions of the study.

Overall, the investigators hypothesize that the groups tested will differ in their neural indices of auditory perception, neural indices of perceptual organization, and induced neural oscillations. Further, the investigators hypothesize that differences in the degree of language impairment across these groups will be correlated with differences in the degree of abnormality of the measured neural indices, but not in the form of the abnormality, suggesting that the root causes of the differences across the tested subject groups are quantitative rather than qualitative.


Recruitment information / eligibility

Status Completed
Enrollment 88
Est. completion date August 30, 2019
Est. primary completion date May 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 14 Years to 21 Years
Eligibility Inclusion Criteria:

- Between the ages of 14 and 21

- Minimally verbal (which is defined as having fewer than 10 words/phrases used communicatively during the Autism Diagnostic Observation Schedule (ADOS) assessment

- Demonstrated minimal progress in speech acquisition despite having participated in speech therapy for at least 18 months

- Diagnosis of Autism Spectrum Disorder (ASD)

- Verbal but language impaired (defined as more than 1.25 standard deviation below the mean on the clinical evaluation of language fundamentals - Fourth edition (CELF-4))

- Has normal language scores (on the CELF-4)

- Is typically developing with no history of psychiatric or neurological disorders

Exclusion Criteria:

- Has contraindications to having a magnetic resonance imaging (MRI) scan (e.g. electronic/ferromagnetic implant, clips, stents, existing or planned major dental work)

- Has a history of significant neurological diseases

- Has a history of sensory impairment (e.g., hearing impairment)

- Has a history of disorders other than ASD

- Is currently taking antipsychotic medications.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No Intervention
Intervention is not a part of this study.

Locations

Country Name City State
United States Boston University Boston Massachusetts

Sponsors (5)

Lead Sponsor Collaborator
Boston University Charles River Campus Massachusetts General Hospital, National Institute on Deafness and Other Communication Disorders (NIDCD), National Institutes of Health (NIH), Northeastern University

Country where clinical trial is conducted

United States, 

References & Publications (1)

Tager-Flusberg H, Kasari C. Minimally verbal school-aged children with autism spectrum disorder: the neglected end of the spectrum. Autism Res. 2013 Dec;6(6):468-78. doi: 10.1002/aur.1329. Epub 2013 Oct 7. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Autism Spectrum Diagnosis Interview 5 years
Primary Adaptive Behaviors Interview 5 years
Primary Cognitive Abilities Interview 5 years
Primary Language Abilities Interview and Questionnaire 5 years
Primary Social Behavior Interview 5 years
Primary Repetitive Behavior Questionnaire 5 years
Primary Sensory Behavior Questionnaire 5 years
Primary Atypical Behavior Questionnaire 5 years
Primary Psychopathology Questionnaire 5 years
Primary Emotion Regulation Questionnaire 5 years
Primary Handedness Questionnaire 5 years
Primary Brain measures of structural and functional connectivity in key nodes of the speech production network In particular between the supplementary motor area (SMA) and ventral premotor cortex (vPMC), a set of nodes in the speech network that is critical for the initiation of speech motor programs. High resolution MRI brain scans collected from adolescents with ASD who vary in their language ability from minimally verbal to normal (and a typical control group). Measures of structural anatomical connectivity based on Diffusion Tensor Imaging (DTI) data and functional connectivity based on resting state functional connectivity MRI. 5 years
Primary Electrophysiological measures and neural oscillatory patterns of the perception, organization and analysis of auditory scenes. Physiological parameter 5 years
Primary Indices of social attention deployment measured by unobtrusively recording participants' eye-movements during the passive viewing of brief realistic video-clips. Physiological parameter 5 years
Primary Indices of electrodermal activity (EDA) measured wirelessly with the Q sensor (a small wearable device designed to work in real-world environments in an untethered, unobtrusive way). Physiological parameter 5 years
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02625116 - ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders
Not yet recruiting NCT06381856 - Improving Participation of Autistic Children and Adolescents in the Habilitation Process
Recruiting NCT02280746 - Gluten for Autism Spectrum Disorders N/A
Completed NCT01945957 - Brain Imaging of Intranasal Oxytocin Treatment in Autism Phase 1
Completed NCT01661855 - A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD Phase 2
Completed NCT01691066 - Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder N/A
Completed NCT01694667 - Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder Phase 2
Completed NCT01780090 - Handheld Technology for Speech Development in Students With Autism N/A
Completed NCT01592747 - Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Phase 2
Active, not recruiting NCT01417026 - Intranasal Oxytocin and Learning in Autism Phase 2
Enrolling by invitation NCT01364818 - Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment N/A
Completed NCT01695200 - Omega-3 Fatty Acids in Autism Spectrum Disorders Phase 4
Completed NCT02300597 - Internet-based Support for Young People With ADHD and Autism - a Controlled Study N/A
Not yet recruiting NCT00695812 - The Development of Younger Siblings of Children With Autism Now at 10 Years of Age N/A
Completed NCT01675414 - Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD) N/A
Recruiting NCT05910502 - Project AFECT (Autism Family Empowerment Coaching and Training Program) N/A
Completed NCT02081027 - Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders Early Phase 1
Completed NCT02797379 - The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders N/A
Terminated NCT01730079 - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed NCT01603225 - Transcranial Direct Current Stimulation and Autism